SCHEMBL22609246

SCHEMBL22609246

O=C(Nc1ccc(Cl)nn1)C1CC2(C1)CN(C(=O)O)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WNT1 P04628 5/20 0.37
GSK3B P49841 5/20 0.37
DYRK1A Q13627 5/20 0.37
FAAH O00519 1/20 0.37
GAA P10253 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 1/20 0.36
EPHX2 P34913 1/20 0.35
POLB P06746 1/20 0.34
DEGS1 O15121 1/20 0.34
JAK2 O60674 1/20 0.33
TYK2 P29597 1/20 0.33
ADORA2B P29275 1/20 0.33
HPGD P15428 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
PTBP1 P26599 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22797253 0.84 PTPN2 (0.46) WNT1GSK3BDYRK1ALMNA
SCHEMBL22609210 0.82 GAA (0.38) FAAHGAAALDH1A1MAPTLMNA
SCHEMBL20919960 0.79 FAAH (0.40) FAAHGAAALDH1A1MAPTLMNA
SCHEMBL28384635 0.76 FAAH (0.38) FAAHALDH1A1LMNAHTTEPHX2
SCHEMBL22609334 0.75 GSK3B (0.39) WNT1GSK3BDYRK1A
SCHEMBL5190502 0.72 ROCK2 (0.44) WNT1GSK3BDYRK1AGAAALDH1A1
SCHEMBL20919945 0.70 FAAH (0.37) FAAHGAAALDH1A1MAPTLMNA
SCHEMBL20936930 0.69 HRH4 (0.39) FAAHGAAALDH1A1MAPTLMNA
SCHEMBL22489679 0.69 LMNA (0.51) LMNAHTTSMN1; SMN2
SCHEMBL15201093 0.68 MAPT (0.52) FAAHGAAALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11325896-B2 Antagonists of the muscarinic acetylcholine receptor M4 VANDERBILT UNIVERSITY (US) 2022-05-10 US disclosed
US-20200392117-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2020-12-17 US disclosed
EP-3732163-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 Vanderbilt University (US) 2020-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392117-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM2, CHRM3, CHRM4 WNT1 4356/4885GSK3B 4245/4885DYRK1A 2753/4885
US-11325896-B2 Antagonists of the muscarinic acetylcholine receptor M4 CHRM2, CHRM3, CHRM5 WNT1 4327/4885GSK3B 4258/4885DYRK1A 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.